We are live on ! Find out more
VF

Virtu Financial Portfolio holdings

AUM $2.41B
1-Year Est. Return 48.35%
This Fund
S&P 500
This Quarter Est. Return
-15.2%
1 Year Est. Return
+48.35%
3 Year Est. Return
+116.81%
5 Year Est. Return
+139.6%
10 Year Est. Return
AUM
$1.18B
AUM Growth
-$173M
Cap. Flow
+$50M
Cap. Flow %
4.25%
Top 10 Hldgs %
31.89%
Holding
2,429
New
979
Increased
279
Reduced
240
Closed
895

Sector Composition

Rank Sector Weight
1 Technology 14.05%
2 Healthcare 13.79%
3 Financials 8.37%
4 Communication Services 8.09%
5 Industrials 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BODI icon
1301
The Beachbody Company
BODI
$45.8M
$24K ﹤0.01%
401
-121
-23% -$9.8K
MKD
1302
DELISTED
Molecular Data Inc. American Depositary Shares
MKD
$24K ﹤0.01%
41,947
+20,898
+99% +$30.1K
PTE
1303
DELISTED
PolarityTE, Inc. Common Stock
PTE
$24K ﹤0.01%
+16,415
New +$59.4K
AVAH icon
1304
Aveanna Healthcare
AVAH
$1.95B
$23K ﹤0.01%
+10,108
New +$29.3K
VIOT
1305
Viomi Technology
VIOT
$49.6M
$23K ﹤0.01%
13,228
+3,122
+31% +$5.04K
LEV.WS
1306
DELISTED
The Lion Electric Company Redeemable Warrants, each whole warrant entitles the holder to purchase one Common Share at a price of $11.50 per share
LEV.WS
$23K ﹤0.01%
26,358
+8,524
+48% +$12.2K
BIMI
1307
DELISTED
BIMI International Medical Inc. Common Stock
BIMI
$23K ﹤0.01%
+3,561
New +$28K
VYNT
1308
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$23K ﹤0.01%
+5,122
New +$22.5K
NBRV
1309
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$23K ﹤0.01%
5,103
+1,921
+60% +$12.5K
ITRM
1310
DELISTED
Iterum Therapeutics
ITRM
$22K ﹤0.01%
7,365
-11,491
-61% -$43K
KALA icon
1311
KALA BIO
KALA
$16.3M
$22K ﹤0.01%
30
-26
-46% -$40.8K
OESX icon
1312
Orion Energy Systems
OESX
$80.8M
$22K ﹤0.01%
+1,070
New +$26.3K
OTLK icon
1313
Outlook Therapeutics
OTLK
$211M
$22K ﹤0.01%
+1,056
New +$30.4K
SNCR
1314
DELISTED
Synchronoss Technologies
SNCR
$22K ﹤0.01%
+2,171
New +$27.5K
EFTR
1315
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$22K ﹤0.01%
+627
New +$37.9K
SNCE
1316
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$22K ﹤0.01%
544
-19
-3% -$1.39K
CRTD
1317
DELISTED
Creatd Inc. Common Stock
CRTD
$22K ﹤0.01%
+30,272
New +$28K
AEI icon
1318
Alset
AEI
$40.1M
$21K ﹤0.01%
+3,493
New +$28.7K
BAOS icon
1319
Baosheng Media Group
BAOS
$1.12M
$21K ﹤0.01%
3,043
+2,121
+230% +$20.3K
LCTX icon
1320
Lineage Cell Therapeutics
LCTX
$283M
$21K ﹤0.01%
+13,380
New +$17.6K
RGLS
1321
DELISTED
Regulus Therapeutics
RGLS
$21K ﹤0.01%
+10,205
New +$24.8K
RMTI icon
1322
Rockwell Medical
RMTI
$27.9M
$21K ﹤0.01%
+1,596
New +$42.2K
AWH
1323
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$21K ﹤0.01%
+2,422
New +$24.6K
ARTL icon
1324
Artelo Biosciences
ARTL
$2.6M
$20K ﹤0.01%
234
+146
+166% +$14.4K
BLRX
1325
BioLineRX
BLRX
$12.1M
$20K ﹤0.01%
+390
New +$21.7K

Similar funds

Virtu Financial's Q2 2022 Portfolio in Review

As of Q2 2022, Virtu Financial held 2,429 positions worth $1.18B, down 13% from $1.35B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Virtu Financial deployed $50M of net new capital in Q2 2022, opening 979 new positions and adding to 279 existing holdings. Its largest new stake was CMC Materials, Inc. Common Stock: 361,092 shares worth $63M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Berkshire Hathaway Class A, an estimated $258M trimmed.

  • Virtu Financial's largest Q2 2022 buy was CMC Materials, Inc. Common Stock: 361,092 shares worth $63M.
  • Virtu Financial added most to Coherent Inc in Q2 2022, an estimated $62.2M increase.
  • Virtu Financial's biggest Q2 2022 reduction was Berkshire Hathaway Class A, cutting an estimated $258M.
  • Virtu Financial fully exited People's United Financial Inc in Q2 2022, selling an estimated $105M.
  • Virtu Financial's ten largest holdings make up 32% of its $1.18B portfolio in Q2 2022.
  • Virtu Financial opened 979 new positions and closed 895 in Q2 2022.
  • Virtu Financial's portfolio value fell 13% quarter-over-quarter to $1.18B.

Based on Virtu Financial's 13F filing for Q2 2022, filed 9 Aug 2022.